Filing Details

Accession Number:
0001179110-20-010870
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-06 16:35:55
Reporting Period:
2020-11-04
Accepted Time:
2020-11-06 16:35:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1707685 Marie Christine Utter C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Svp, Finance & Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-04 1,567 $30.86 11,129 No 4 M Direct
Common Stock Disposition 2020-11-04 1,567 $60.20 9,562 No 4 S Direct
Common Stock Acquisiton 2020-11-04 688 $30.86 10,250 No 4 M Direct
Common Stock Disposition 2020-11-04 688 $60.00 9,562 No 4 S Direct
Common Stock Acquisiton 2020-11-04 355 $18.01 9,917 No 4 M Direct
Common Stock Disposition 2020-11-04 355 $60.00 9,562 No 4 S Direct
Common Stock Acquisiton 2020-11-04 2,500 $18.01 12,062 No 4 M Direct
Common Stock Disposition 2020-11-04 2,500 $60.00 9,562 No 4 S Direct
Common Stock Acquisiton 2020-11-04 8,055 $30.86 17,617 No 4 M Direct
Common Stock Disposition 2020-11-04 8,055 $60.20 9,562 No 4 S Direct
Common Stock Acquisiton 2020-11-04 2,656 $33.02 12,218 No 4 M Direct
Common Stock Disposition 2020-11-04 2,656 $60.00 9,562 No 4 S Direct
Common Stock Acquisiton 2020-11-04 2,656 $33.02 12,218 No 4 M Direct
Common Stock Disposition 2020-11-04 2,656 $60.00 9,562 No 4 S Direct
Common Stock Acquisiton 2020-11-04 10,625 $33.02 20,187 No 4 M Direct
Common Stock Disposition 2020-11-04 10,625 $60.00 9,562 No 4 S Direct
Common Stock Acquisiton 2020-11-04 2,656 $33.02 12,218 No 4 M Direct
Common Stock Disposition 2020-11-04 2,656 $60.00 9,562 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right To Buy) Disposition 2020-11-04 1,567 $30.86 1,567 $30.86
Common Stock Stock Option (Right to Buy) Disposition 2020-11-04 688 $30.86 688 $30.86
Common Stock Stock Option (Right to Buy) Disposition 2020-11-04 355 $18.01 355 $18.01
Common Stock Stock Option (Right to Buy) Disposition 2020-11-04 2,500 $18.01 2,500 $18.01
Common Stock Stock Option (Right to Buy) Disposition 2020-11-04 8,055 $30.86 8,055 $30.86
Common Stock Stock Option (Right To Buy) Disposition 2020-11-04 2,656 $33.02 2,656 $33.02
Common Stock Stock Option (Right to Buy) Disposition 2020-11-04 2,656 $33.02 2,656 $33.02
Common Stock Stock Option (Right to Buy) Disposition 2020-11-04 10,625 $33.02 10,625 $33.02
Common Stock Stock Option (Right to Buy) Disposition 2020-11-04 2,656 $33.02 2,656 $33.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,743 2026-01-03 No 4 M Direct
8,055 2026-01-03 No 4 M Direct
15,000 2028-01-02 No 4 M Direct
12,500 2028-01-02 No 4 M Direct
0 2026-01-03 No 4 M Direct
39,844 2029-01-21 No 4 M Direct
37,188 2029-01-21 No 4 M Direct
26,563 2029-01-21 No 4 M Direct
23,907 2029-01-21 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right To Buy) $490.80 2021-04-27 74 74 Direct
Common Stock Stock Option (Right To Buy) $218.40 2022-01-10 21 21 Direct
Common Stock Stock Option (Right To Buy) $40.45 2024-09-23 4,688 4,688 Direct
Common Stock Stock Option (Right To Buy) $51.00 2025-01-02 17,800 17,800 Direct
Common Stock Stock Option (Right To Buy) $11.23 2027-01-02 788 788 Direct
Common Stock Stock Option (Right To Buy) $33.02 2029-01-21 10,100 10,100 Direct
Common Stock Stock Option (Right To Buy) $51.16 2030-01-28 23,800 23,800 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-04-27 74 74 Direct
2022-01-10 21 21 Direct
2024-09-23 4,688 4,688 Direct
2025-01-02 17,800 17,800 Direct
2027-01-02 788 788 Direct
2029-01-21 10,100 10,100 Direct
2030-01-28 23,800 23,800 Direct
Footnotes
  1. This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019.
  2. Currently exercisable.
  3. This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
  4. This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
  5. This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
  6. This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
  7. This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.